Gene · 1548
Papers4,152
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,152
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CHRNA5-A3-B4, CYP2A6, and DBH Genetic Associations With Smoking Cessation Throughout Adulthood Within Two Longitudinal Studies of Women. | Nicotine Tob Res | 2025 | 39673390 | PubTator, text mining | PubMed |
| Artificial intelligence modeling of biomarker-based physiological age: Impact on phase 1 drug-metabolizing enzyme phenotypes. | CPT Pharmacometrics Syst Pharmacol | 2025 | 39540677 | PubTator, text mining | PubMed |
| Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers. | Mol Psychiatry | 2025 | 39217253 | PubTator, text mining | PubMed |
| Long-Term PM2.5 Exposure and Upregulation of CLCA1 Expression in Nasal Epithelium from Youth with Asthma. | Ann Am Thorac Soc | 2025 | 38986136 | PubTator, text mining | PubMed |
| Genetic variations in CYP2A6, CYP2E1, GSTM1, GSTT1 genes and the risk of Nasopharyngeal carcinoma in North African population. | Ann Hum Genet | 2025 | 38622954 | PubTator, text mining | PubMed |
| Pharmacogenetic and pharmacokinetic factors for dexmedetomidine-associated hemodynamic instability in pediatric patients. | Front Pharmacol | 2024 | 39840108 | PubTator, text mining | PubMed |
| Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023. | Front Pharmacol | 2024 | 39830351 | PubTator, text mining | PubMed |
| Heterotropic Activation of Cytochrome P450 3A4 by Perillyl Alcohol. | Pharmaceutics | 2024 | 39771560 | PubTator, text mining | PubMed |
| Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals. | Sci Rep | 2024 | 39730427 | PubTator, text mining | PubMed |
| Integrating genetic and clinical data to predict lung cancer in patients with chronic obstructive pulmonary disease. | BMC Pulm Med | 2024 | 39696223 | PubTator, text mining | PubMed |
| A systematic review of dexmedetomidine pharmacology in pediatric patients. | Clin Transl Sci | 2024 | 39644147 | PubTator, text mining | PubMed |
| Redefining copy number variation and single-nucleotide polymorphism counting via novel concepts based on recent PCR enhancements. | Biochem Biophys Res Commun | 2024 | 39571227 | PubTator, text mining | PubMed |
| Genetic susceptibility to caffeine intake and metabolism: a systematic review. | J Transl Med | 2024 | 39438936 | PubTator, text mining | PubMed |
| A Systematic Review Exploring Empirical Pharmacogenomics Research Within Global Indigenous Populations. | Mol Genet Genomic Med | 2024 | 39435544 | PubTator, text mining | PubMed |
| Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells. | Regul Toxicol Pharmacol | 2024 | 39433234 | PubTator, text mining | PubMed |
| Machine Learning-Based In Silico Prediction of the Inhibitory Activity of Chemical Substances Against Rat and Human Cytochrome P450s. | Chem Res Toxicol | 2024 | 39427263 | PubTator, text mining | PubMed |
| Non-additivity of the functional properties of individual P450 species and its manifestation in the effects of alcohol consumption on the metabolism of ketamine and amitriptyline. | Biochem Pharmacol | 2024 | 39393643 | PubTator, text mining | PubMed |
| Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences. | Sci Rep | 2024 | 39354004 | PubTator, text mining | PubMed |
| Development of a high throughput cytochrome P450 ligand-binding assay. | J Biol Chem | 2024 | 39305957 | PubTator, text mining | PubMed |
| DNA methylation and gene expression profiling reveal potential association of retinol metabolism related genes with hepatocellular carcinoma development. | PeerJ | 2024 | 39193514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1548/papers?page=5